Australian and New Zealand Registry of Advanced Glaucoma: methodology and recruitment
Emmanuelle Souzeau, Ivan Goldberg, Paul R Healey, Richard AD Mills, John Landers, Stuart L Graham, John RB Grigg, Bronwyn Usher, Tania Straga, April Crawford, Robert J Casson, William H Morgan, Jonathan B Ruddle, Michael A Coote, Andrew White, James Stewart, Alex W Hewitt, David A Mackey, Kathryn P Burdon, Jamie E Craig
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | WILEY-BLACKWELL | Published : 2012
BACKGROUND: Glaucoma is a sight-threatening disease affecting 3% of the population over the age of 50. Glaucoma is treatable, and severe vision loss can usually be prevented if diagnosis is made at an early stage. Genetic factors play a major role in the pathogenesis of the condition, and therefore, genetic testing to identify asymptomatic at-risk individuals is a promising strategy to reduce the prevalence of glaucoma blindness. Furthermore, unravelling genetic risk factors for glaucoma would also allow a better understanding of the pathogenesis of the condition and the development of new treatments. DESIGN: The Australian and New Zealand Registry of Advanced Glaucoma is a prospective s..View full abstract
This project is supported by The Eye Foundation (http://www.eyefoundation.org.au). KPB is supported by a National Health and Medical Research Council (NHMRC) Career Development Award and JEC is an NHMRC Practitioner Fellow.